{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T02:47:14Z","timestamp":1772160434392,"version":"3.50.1"},"reference-count":21,"publisher":"Wiley","issue":"12","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1434,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1111\/j.1346-8138.2011.01223.x","type":"journal-article","created":{"date-parts":[[2011,9,28]],"date-time":"2011-09-28T09:01:04Z","timestamp":1317200464000},"page":"1135-1139","source":"Crossref","is-referenced-by-count":27,"title":["Pimecrolimus 1% cream for the treatment of rosacea"],"prefix":"10.1111","volume":"38","author":[{"given":"Moon-Bum","family":"KIM","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gun-Wook","family":"KIM","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyun-Je","family":"PARK","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hoon-Soo","family":"KIM","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyun-Woo","family":"CHIN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Su-Han","family":"KIM","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Byung-Soo","family":"KIM","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyun-Chang","family":"KO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2011,9,28]]},"reference":[{"key":"10.1111\/j.1346-8138.2011.01223.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1056\/NEJMcp042829","article-title":"Clinical practice. Rosacea","volume":"352","author":"Powell","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1346-8138.2011.01223.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.jaad.2004.01.048","article-title":"Standard grading system for rosacea: report of the National Rosacea Society Expert Committee on the classification and staging of rosacea","volume":"50","author":"Wilkin","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1346-8138.2011.01223.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jdermsci.2009.04.007","article-title":"The molecular pathology of rosacea","volume":"55","author":"Yamasaki","year":"2009","journal-title":"J Dermatol Sci"},{"key":"10.1111\/j.1346-8138.2011.01223.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.jaad.2004.03.030","article-title":"Rosacea: I. Etiology, pathogenesis, and subtype classification","volume":"51","author":"Crawford","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1346-8138.2011.01223.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.jaad.2004.03.012","article-title":"Rosacea subtype-directed therapy","volume":"51","author":"Heymann","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1346-8138.2011.01223.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1111\/j.0906-6705.2004.00269.x","article-title":"Pimecrolimus - an anti-inflammatory drug targeting the skin","volume":"13","author":"Grassberger","year":"2004","journal-title":"Exp Dermatol"},{"key":"10.1111\/j.1346-8138.2011.01223.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1046\/j.1468-3083.2003.00692.x","article-title":"Pimecrolimus: a review","volume":"17","author":"Gupta","year":"2003","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1111\/j.1346-8138.2011.01223.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1540-9740.2005.03740.x","article-title":"Pimecrolimus for treatment of acne rosacea","volume":"4","author":"Crawford","year":"2005","journal-title":"Skinmed"},{"key":"10.1111\/j.1346-8138.2011.01223.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1080\/00015550510043975","article-title":"Pimecrolimus cream 1% is effective in a case of granulomatous rosacea","volume":"86","author":"Cunha","year":"2006","journal-title":"Acta Derm Venereol"},{"key":"10.1111\/j.1346-8138.2011.01223.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1111\/j.1365-2133.2006.07669.x","article-title":"Pimecrolimus cream 1% for papulopustular rosacea: a randomized vehicle-controlled double-blind trial","volume":"156","author":"Weissenbacher","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1346-8138.2011.01223.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1080\/09546630802032595","article-title":"A case of granulomatous rosacea successfully treated with pimecrolimus cream","volume":"19","author":"Gul","year":"2008","journal-title":"J Dermatolog Treat"},{"key":"10.1111\/j.1346-8138.2011.01223.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1111\/j.1468-3083.2008.02589.x","article-title":"A randomized, single-blind, placebo-controlled, split-face study with pimecrolimus cream 1% for papulopustular rosacea","volume":"22","author":"Karabulut","year":"2008","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1111\/j.1346-8138.2011.01223.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/j.1365-2230.2009.03427.x","article-title":"A comparison of metronidazole 1% cream and pimecrolimus 1% cream in the treatment of patients with papulopustular rosacea: a randomized open-label clinical trial","volume":"35","author":"Koca","year":"2010","journal-title":"Clin Exp Dermatol"},{"key":"10.1111\/j.1346-8138.2011.01223.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1111\/j.1468-3083.2006.01991.x","article-title":"An open-label pilot study to evaluate the safety and efficacy of topically applied pimecrolimus cream for the treatment of steroid-induced rosacea-like eruption","volume":"21","author":"Chu","year":"2007","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1111\/j.1346-8138.2011.01223.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1067\/mjd.2003.308","article-title":"Efficacy and safety of azelaic acid (15%) gel as a new treatment for papulopustular rosacea: results from two vehicle-controlled, randomized phase III studies","volume":"48","author":"Thiboutot","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1346-8138.2011.01223.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.jaad.2004.03.033","article-title":"Rosacea: II. Therapy","volume":"51","author":"Pelle","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1346-8138.2011.01223.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"479","DOI":"10.2165\/00128071-200405060-00013","article-title":"Pimecrolimus: a review of its use in atopic dermatitis","volume":"5","author":"Wellington","year":"2004","journal-title":"Am J Clin Dermatol"},{"key":"10.1111\/j.1346-8138.2011.01223.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1111\/j.1365-2133.2008.08496.x","article-title":"Pimecrolimus 1% cream for the treatment of steroid-induced rosacea: an 8-week split-face clinical trial","volume":"158","author":"Lee","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1346-8138.2011.01223.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1111\/j.1365-2133.2005.06404.x","article-title":"The use of 1% pimecrolimus cream for the treatment of steroid-induced rosacea","volume":"152","author":"Chu","year":"2005","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1346-8138.2011.01223.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1001\/archderm.141.9.1168","article-title":"Rosaceiform dermatitis as a complication of treatment of facial seborrheic dermatitis with 1% pimecrolimus cream","volume":"141","author":"Gorman","year":"2005","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1346-8138.2011.01223.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.jaad.2005.04.053","article-title":"Rosaceiform eruption to pimecrolimus","volume":"54","author":"El","year":"2006","journal-title":"J Am Acad Dermatol"}],"container-title":["The Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1346-8138.2011.01223.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1346-8138.2011.01223.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,12]],"date-time":"2024-04-12T20:25:37Z","timestamp":1712953537000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1346-8138.2011.01223.x"}},"subtitle":["Pimecrolimus cream for rosacea"],"short-title":[],"issued":{"date-parts":[[2011,9,28]]},"references-count":21,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2011,12]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1346-8138.2011.01223.x","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.718430985.793495894","asserted-by":"object"}]},"ISSN":["0385-2407"],"issn-type":[{"value":"0385-2407","type":"print"}],"subject":[],"published":{"date-parts":[[2011,9,28]]}}}